Veritas Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avery Dennison
AVY
|
+$46.5M |
| 2 |
Amphenol
APH
|
+$36.6M |
| 3 |
CERN
Cerner Corp
CERN
|
+$7M |
| 4 |
UnitedHealth
UNH
|
+$4.61M |
| 5 |
Microsoft
MSFT
|
+$4.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$11.9M |
| 2 |
CVS Health
CVS
|
+$705K |
| 3 |
Moody's
MCO
|
+$298K |
| 4 |
Johnson & Johnson
JNJ
|
+$238K |
| 5 |
Roper Technologies
ROP
|
+$183K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.63% |
| 2 | Technology | 27.75% |
| 3 | Financials | 16.41% |
| 4 | Communication Services | 7% |
| 5 | Industrials | 5.76% |
Similar funds
Veritas Investment Management's Q1 2019 Portfolio in Review
As of Q1 2019, Veritas Investment Management held 67 positions worth $1.02B, up 25% from $821M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Veritas Investment Management deployed $99M of net new capital in Q1 2019, opening 1 new position and adding to 12 existing holdings. Its largest new stake was Avery Dennison: 449,828 shares worth $50.8M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 36% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Fiserv Inc, an estimated $11.9M trimmed.
- Veritas Investment Management's largest Q1 2019 buy was Avery Dennison: 449,828 shares worth $50.8M.
- Veritas Investment Management added most to Amphenol in Q1 2019, an estimated $36.6M increase.
- Veritas Investment Management's biggest Q1 2019 reduction was Fiserv Inc, cutting an estimated $11.9M.
- Veritas Investment Management fully exited Roper Technologies in Q1 2019, selling an estimated $183K.
- Veritas Investment Management's ten largest holdings make up 78% of its $1.02B portfolio in Q1 2019.
- Veritas Investment Management opened 1 new position and closed 7 in Q1 2019.
- Veritas Investment Management's portfolio value rose 25% quarter-over-quarter to $1.02B.
Based on Veritas Investment Management's 13F filing for Q1 2019, filed 7 May 2019.